Novo Nordisk locked in legal battle over generic drug

Jan. 16, 2014

Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.

Danish pharmaceutical giant Novo Nordisk is being sued by several U.S. healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market, according to Reuters.

A spokesperson for the company told Reuters that Novo Nordisk hopes to have the case dismissed but did not provide any further comments regarding the lawsuit.

The news service reported that Novo's Prandin patent was due to expire in 2009. Four years prior to that, in 2005, a subsidiary of Indian pharmaceutical company Sun Pharmaceuticals, Caraco Pharmaceutical Laboratories, applied for approval of a generic version of the drug with a view to taking a share of the U.S. market when Prandin came off patent. That same year, in June 2005, Novo started a patent infringement lawsuit against Caraco but eventually lost.

RELATED: Generics dent market share of brand-name drugs

The companies that are suing Novo allege that the earlier lawsuit, which only closed last summer, had delayed the launch of generic versions of Prandin and they are seeking financial compensation for the losses they incurred. The healthcare purchasing companies involved in the lawsuit include American Sales Co., Rochester Drug Co-op and Cardinal.

Data quoted by Reuters showed that sales of the diabetic drug a year before it lost its exclusivity came in at $438 million.

Sponsored Recommendations

2024 Manufacturing Trends — Unpacking AI, Workforce, and Cybersecurity

The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

State of Smart Manufacturing Report Series

The world of manufacturing is changing, and Generative AI is one of the many change agents. The 2024 State of Smart Manufacturing Report takes a deep dive into how Generative ...

Embracing Sustainability through Control Technology

To meet global demand for fish products in a sustainable way, new thinking is essential. Find out how Sustainable Blue worked with Fairfield Control Systems and Rockwell Automation...

Better OT Asset Management Increases Uptime

A food and beverage company streamlines and simplifies its OT cybersecurity to increase system reliability and uptime.